![Vasant Prakash Gandhi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Vasant Prakash Gandhi
Algemeen Directeur bij Molecular Decisions Strategy LLC
Actieve functies van Vasant Prakash Gandhi
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Molecular Decisions Strategy LLC | Algemeen Directeur | - | - |
Loopbaan van Vasant Prakash Gandhi
Eerdere bekende functies van Vasant Prakash Gandhi
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Abraxis BioScience, Inc.
![]() Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | 30-03-2011 | 30-03-2011 |
AMGEN INC. | Algemeen Adviseur | 01-06-2007 | 01-06-2007 |
Portefeuillebeheerder-Aandelen | 01-06-2007 | 01-06-2007 | |
Immunex Corp.
![]() Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Algemeen Adviseur | 01-07-2002 | 01-07-2002 |
Avesthagen Ltd.
![]() Avesthagen Ltd. Miscellaneous Commercial ServicesCommercial Services Avesthagen Ltd. provides personalized healthcare through convergence of food, pharma and population genetics. It offers genome analysis, transcriptome analysis, metabolome analysis and lead optimization, and recombinant protein expression services, as well as engages in the generation of stable mammalian cell lines over-expressing a recombinant protein, development of product specific bioassays, and design of novel animal component free production media. The company was founded by Villoo Morwala Zareer Patell on April 20, 1998 and is headquartered in Bangalore, India. | Corporate Officer/Principal | - | - |
ApoVax, Inc.
![]() ApoVax, Inc. Medical/Nursing ServicesHealth Services ApoVax, Inc. developed immunotherapies and therapeutic vaccines. It was a biotechnology company that developed novel immunotherapies, which are treatments based on regulating the host immune system to fight disease. The firm was a scientific foundation that built on two platform technologies that are used to modulate the immune system-ProtEx and ApoVax. The company was founded by Haval Shirwan in 2001 and was headquartered in Louisville, KY. | Corporate Officer/Principal | - | - |
Opleiding van Vasant Prakash Gandhi
Loyola University of Chicago | Doctorate Degree |
University of Illinois | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 8 |
India | 2 |
Operationeel
Corporate Officer/Principal | 3 |
General Counsel | 2 |
Portfolio Manager-Equities | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 3 |
Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
AMGEN INC. | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Immunex Corp.
![]() Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Health Technology |
Abraxis BioScience, Inc.
![]() Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Health Technology |
ApoVax, Inc.
![]() ApoVax, Inc. Medical/Nursing ServicesHealth Services ApoVax, Inc. developed immunotherapies and therapeutic vaccines. It was a biotechnology company that developed novel immunotherapies, which are treatments based on regulating the host immune system to fight disease. The firm was a scientific foundation that built on two platform technologies that are used to modulate the immune system-ProtEx and ApoVax. The company was founded by Haval Shirwan in 2001 and was headquartered in Louisville, KY. | Health Services |
Molecular Decisions Strategy LLC | |
Avesthagen Ltd.
![]() Avesthagen Ltd. Miscellaneous Commercial ServicesCommercial Services Avesthagen Ltd. provides personalized healthcare through convergence of food, pharma and population genetics. It offers genome analysis, transcriptome analysis, metabolome analysis and lead optimization, and recombinant protein expression services, as well as engages in the generation of stable mammalian cell lines over-expressing a recombinant protein, development of product specific bioassays, and design of novel animal component free production media. The company was founded by Villoo Morwala Zareer Patell on April 20, 1998 and is headquartered in Bangalore, India. | Commercial Services |